Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evoke Pharma ROA 2012-2024 | EVOK

Current and historical return on assets (ROA) values for Evoke Pharma (EVOK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Evoke Pharma ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $-0.01B $0.01B -53.33%
2024-06-30 $-0.01B $0.01B -71.79%
2024-03-31 $-0.01B $0.01B -88.89%
2023-12-31 $-0.01B $0.01B -94.12%
2023-09-30 $-0.01B $0.01B -82.05%
2023-06-30 $-0.01B $0.01B -72.73%
2023-03-31 $-0.01B $0.01B -65.31%
2022-12-31 $-0.01B $0.01B -66.67%
2022-09-30 $-0.01B $0.01B -68.09%
2022-06-30 $-0.01B $0.01B -69.57%
2022-03-31 $-0.01B $0.01B -64.00%
2021-12-31 $-0.01B $0.01B -60.00%
2021-09-30 $-0.01B $0.01B -62.07%
2021-06-30 $-0.01B $0.02B -67.92%
2021-03-31 $-0.01B $0.02B -130.23%
2020-12-31 $-0.01B $0.01B -179.31%
2020-09-30 $-0.01B $0.01B -184.62%
2020-06-30 $-0.01B $0.01B -184.62%
2020-03-31 $-0.01B $0.01B -107.69%
2019-12-31 $-0.01B $0.01B -112.00%
2019-09-30 $-0.01B $0.01B -128.00%
2019-06-30 $-0.01B $0.01B -128.00%
2019-03-31 $-0.01B $0.00B -133.33%
2018-12-31 $-0.01B $0.01B -123.08%
2018-09-30 $-0.01B $0.01B -85.71%
2018-06-30 $-0.01B $0.01B -112.50%
2018-03-31 $-0.01B $0.01B -94.74%
2017-12-31 $-0.01B $0.01B -102.13%
2017-09-30 $-0.01B $0.01B -116.67%
2017-06-30 $-0.01B $0.01B -100.00%
2017-03-31 $-0.01B $0.02B -130.00%
2016-12-31 $-0.01B $0.01B -137.50%
2016-09-30 $-0.01B $0.01B -145.45%
2016-06-30 $-0.01B $0.01B -141.18%
2016-03-31 $-0.01B $0.01B -120.00%
2015-12-31 $-0.01B $0.01B -113.04%
2015-09-30 $-0.01B $0.01B -101.96%
2015-06-30 $-0.01B $0.01B -107.69%
2015-03-31 $-0.02B $0.01B -103.45%
2014-12-31 $-0.01B $0.02B -82.35%
2014-09-30 $-0.01B $0.01B -66.67%
2014-06-30 $-0.01B $0.02B -40.45%
2014-03-31 $-0.01B $0.02B -27.03%
2013-12-31 $-0.00B $0.03B -15.69%
2013-06-30 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.007B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $25.400B 8.33
Dr Reddy's Laboratories (RDY) India $13.080B 25.03
BridgeBio Pharma (BBIO) United States $5.392B 0.00
Bausch Health Cos (BHC) Canada $2.723B 2.01
Supernus Pharmaceuticals (SUPN) United States $1.966B 26.77
Amphastar Pharmaceuticals (AMPH) United States $1.840B 11.06
Personalis (PSNL) United States $0.430B 0.00
Taysha Gene Therapies (TSHA) United States $0.379B 26.43
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.027B 0.00
Teligent (TLGT) United States $0.000B 0.00